求助7篇文献 不胜感激

aaaszw

0 k% [* n- I5 w/ w9 Z: z" P5 R# i) \$ y" o5 T, D/ A: O; z
Tumor Interferon Signaling Regulates a Multigenic Resistance Program to Immune Checkpoint Blockade.
. g6 h$ S9 q" z% p0 f; zhttps://www.ncbi.nlm.nih.gov/pubmed/279120612 D. S+ J# g- B  F! z

6 q/ j- O$ j% z, k# x; kThe long non-coding RNA Morrbid regulates Bim and short-lived myeloid cell lifespan.' u8 f4 D7 f% @& t
https://www.ncbi.nlm.nih.gov/pubmed/27525555; m0 x. S4 j5 F- {0 q  v- @
- I4 b8 a6 s5 b5 e2 \
Bioenergetic Insufficiencies Due to Metabolic Alterations Regulated by the Inhibitory Receptor PD-1 Are an Early Driver of CD8(+) T Cell Exhaustion
' u. A6 o3 n) I! S1 V1 Ohttps://www.ncbi.nlm.nih.gov/pubmed/27496729
# h6 k7 p/ P) v, q/ ]- |
: D  E9 Z" _% tCutting Edge: B Cell-Intrinsic T-bet Expression Is Required To Control Chronic Viral Infection.
7 g% P3 {6 {: W. H, Ohttps://www.ncbi.nlm.nih.gov/pubmed/27430722; R5 Y7 P- o& R& w& A! u* u3 |, l

0 E4 `$ B: l; U* T$ |+ aCostimulatory and Coinhibitory Receptor Pathways in Infectious Disease.9 z4 X& d. u: r1 `' b1 p: }5 F
https://www.ncbi.nlm.nih.gov/pubmed/27192569$ y: ~- r, ^& `" \/ q

: a3 i/ `! A/ _+ Y# Z' ACombination Cancer Therapies with Immune Checkpoint Blockade: Convergence on Interferon Signaling
" z, x) ]2 Z. U6 e/ d6 Fhttps://www.ncbi.nlm.nih.gov/pubmed/27058661: o) c, P  l1 n8 M" x
# E, _8 S3 K7 F/ Z" D7 W8 N( m
De-Risking Immunotherapy: Report of a Consensus Workshop of the Cancer Immunotherapy Consortium of the Cancer Research Institute
/ v8 d: z7 F# o4 d$ e) a3 t) r0 M" rhttps://www.ncbi.nlm.nih.gov/pubmed/27036972

lchanlon

回复 aaaszw 的帖子$ `0 O! ?8 I% ~4 O" ?

* N, l3 f. X- O/ W4 F- }Here you go
) D. x, _) a2 W% f4 F  B* K0 c
- i, T/ \- }% P% E4 PGood luck!

lchanlon

回复 aaaszw 的帖子
  y7 m% U% q7 k% f4 e3 X8 U, S6 j: L' v, x* v7 e4 k
Here you go
2 \. W0 p7 ]. e: V, N; ^. H& z' \7 W2 H9 Q# u
Good luck!

aaaszw

回复 lchanlon 的帖子: C2 A( ~8 Z8 P5 F+ |
' m0 \. K' F" t4 Z% t- v: ~- m
merci beaucoup ：）